OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Transformation of advanced lung adenocarcinoma to acquired T790M resistance mutation adenosquamous carcinoma following tyrosine kinase inhibitor: a case report
Qinghan Liu, Lin Wu, Suning Zhang
Tumori Journal (2020) Vol. 107, Iss. 6, pp. NP5-NP10
Closed Access | Times Cited: 6
Qinghan Liu, Lin Wu, Suning Zhang
Tumori Journal (2020) Vol. 107, Iss. 6, pp. NP5-NP10
Closed Access | Times Cited: 6
Showing 6 citing articles:
The current state of the art and future trends in RAS-targeted cancer therapies
Salman R. Punekar, Vamsidhar Velcheti, Benjamin G. Neel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 10, pp. 637-655
Open Access | Times Cited: 315
Salman R. Punekar, Vamsidhar Velcheti, Benjamin G. Neel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 10, pp. 637-655
Open Access | Times Cited: 315
Clonal dynamics and Stereo-seq resolve origin and phenotypic plasticity of adenosquamous carcinoma
Ruiying Zhao, Yunhua Xu, Yedan Chen, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Ruiying Zhao, Yunhua Xu, Yedan Chen, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Case Report: Durable partial response to icotinib plus crizotinib in a lung adenocarcinoma patient with double uncommon EGFR G719D/L861Q mutations and an acquired novel CUX1-MET fusion
Lanzi Ou, Yicong Tang, Yanming Deng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Lanzi Ou, Yicong Tang, Yanming Deng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Clinical Features, Molecular Features and Prognosis of Lung Adeno-Squamous Cell Car-cinoma
尚莹 孙
Advances in Clinical Medicine (2023) Vol. 13, Iss. 02, pp. 1770-1776
Closed Access
尚莹 孙
Advances in Clinical Medicine (2023) Vol. 13, Iss. 02, pp. 1770-1776
Closed Access
Effects of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) targeted combined chemotherapy on immune function, tumor markers and oxidative stress in patients with stage IV lung adenocarcinoma
Yanxiao Kun, Jian Wu, Shaomu Chen
Pakistan Journal of Medical Sciences (2023) Vol. 39, Iss. 3
Open Access
Yanxiao Kun, Jian Wu, Shaomu Chen
Pakistan Journal of Medical Sciences (2023) Vol. 39, Iss. 3
Open Access
